US EditionPublished • loading... • Updated
Cel-Sci Corporation (CVM): Investor Outlook On Potential 962.50% Upside In Biotechnology Sector
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cel-Sci Corporation (CVM): Investor Outlook On Potential 962.50% Upside In Biotechnology Sector
Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company with a market capitalization of $33.83 million, is capturing investor attention with a staggering potential upside of 962.50%. Operating in the healthcare sector, Cel-Sci focuses on leveraging the immune system to treat cancer and other diseases. The company is headquartered in Vienna, Virginia, and its innovative approach places it at a unique intersection of biotechnolog…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
